Winthrop Partners - WNY’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$126K Sell
650
-34
-5% -$6.53K 0.09% 134
2019
Q2
$126K Hold
684
0.09% 121
2019
Q1
$131K Sell
684
-350
-34% -$66.8K 0.1% 115
2018
Q4
$201K Hold
1,034
0.19% 92
2018
Q3
$214K Sell
1,034
-147
-12% -$29K 0.17% 101
2018
Q2
$218K Hold
1,181
0.18% 100
2018
Q1
$200K Hold
1,181
0.15% 118
2017
Q4
$226K Buy
+1,181
New +$209K 0.18% 113

Other funds holding AMGN

Winthrop Partners - WNY's AMGN Position: Q3 2019 in Review

Winthrop Partners - WNY reduced its Amgen (AMGN) stake by 5% in Q3 2019, selling an estimated $6.53K and leaving 650 shares worth $126K. The position accounts for 0.09% of the portfolio, ranked #134.

Winthrop Partners - WNY first reported a position in AMGN in Q4 2017 and has held it in 8 quarters since. The position peaked at $226K in Q4 2017. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Winthrop Partners - WNY held 650 shares of Amgen worth $126K as of Q3 2019.
  • Winthrop Partners - WNY sold 34 Amgen shares in Q3 2019, an estimated $6.53K.
  • Amgen made up 0.09% of Winthrop Partners - WNY's portfolio in Q3 2019, its #134 holding.
  • Winthrop Partners - WNY first reported a position in Amgen in Q4 2017 and has held it in 8 quarters since.
  • Winthrop Partners - WNY's Amgen position peaked at $226K in Q4 2017.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.